TITLE

Hypoglycemia and Medical Expenses in Patients with Type 2 Diabetes Mellitus: An Analysis Based on the Korea National Diabetes Program Cohort

AUTHOR(S)
Rhee, Sang Youl; Hong, Soo Min; Chon, Suk; Ahn, Kyu Jeung; Kim, Sung Hoon; Baik, Sei Hyun; Park, Yong Soo; Nam, Moon Suk; Lee, Kwan Woo; Woo, Jeong-Taek; Kim, Young Seol
PUB. DATE
February 2016
SOURCE
PLoS ONE;2/18/2016, Vol. 11 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and Aims: Hypoglycemia is one of the most important adverse events in individuals with type 2 diabetes mellitus (T2DM). However, hypoglycemia-related events are usually overlooked and have been documented less in clinical practice. Materials and Methods: We evaluated the incidence, clinical characteristics, and medical expenses of hypoglycemia related events in T2DM patients based on the Korea National Diabetes Program (KNDP), which is the largest multi-center, prospective cohort in Korea (n = 4,350). For accurate outcomes, the KNDP data were merged with claims data from the Health Insurance Review and Assessment Service (HIRA) of Korea. Results: During a median follow-up period of 3.23 years (95% CI: 3.14, 3.19), 88 subjects (2.02%) were newly diagnosed with hypoglycemia, and the incidence of hypoglycemia was 6.44 cases per 1,000 person-years (PY). Individuals with hypoglycemia were significantly older (59.7±10.7 vs. 53.3±10.4 years, p < 0.001), had more hospital visits (121.94±126.88 days/PY, p < 0.001), had a longer hospital stays (16.13±29.21 days/PY, p < 0.001), and incurred greater medical costs ($2,447.56±4,056.38 vs. $1,336.37±3,403.39 /PY, p < 0.001) than subjects without hypoglycemia. Conclusion: Hypoglycemia-related events were infrequently identified among the medical records of T2DM subjects. However, they were associated significantly with poor clinical outcomes, and thus, hypoglycemia could have a substantial burden on the Korean national healthcare system.
ACCESSION #
113114498

 

Related Articles

  • Hypoglycaemia exacts extra costs in Canada.  // PharmacoEconomics & Outcomes News;7/24/2010, Issue 608, p7 

    The article discusses research on the association of hypoglycemia with medication, discontinuation and costs in type 2 diabetes mellitus patients in Canada, referencing a study by M. Bron and colleagues presented at the 70th Annual Scientific Sessions of the American Diabetes Association.

  • The Direct Medical Cost of Type 2 Diabetes. Brandle, Michael; Zhou, Honghong; Smith, Barbara R.K.; Marriott, Deanna; Burke, Ray; Tabaei, Bahman P.; Brown, Morton B.; Herman, William H. // Diabetes Care;Aug2003, Vol. 26 Issue 8, p2300 

    OBJECTIVE — To describe the direct medical costs associated with type 2 diabetes, as well as its treatments, complications, and comorbidities. RESEARCH DESIGN AND METHODS — We studied a random sample of 1,364 subjects with type 2 diabetes who were members of a Michigan health...

  • Type 2 Diabetes: Incremental Medical Care Costs During the First 8 Years After Diagnosis. Brown, Jonathan B.; Nichols, Gregory A.; Glauber, Harry S.; Bakst, Alan W. // Diabetes Care;Jul99, Vol. 22 Issue 7, p1116 

    Presents information on a study that described and analyzed the time course of medical care costs caused by type 2 diabetes, from the time of diagnosis through the first postdiagnostic years. Research design and methods; Results; Conclusions.

  • Differential Cardiovascular Outcomes after Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Pioglitazone Therapy, All in Combination with Metformin, for Type 2 Diabetes: A Population-Based Cohort Study. Seong, Jong-Mi; Choi, Nam-Kyong; Shin, Ju-Young; Chang, Yoosoo; Kim, Ye-Jee; Lee, Joongyub; Kim, Ju-Young; Park, Byung-Joo // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Background/Objectives: Data on the comparative effectiveness of oral antidiabetics on cardiovascular outcomes in a clinical practice setting are limited. This study sought to determine whether a differential risk of cardiovascular disease (CVD) exists for the combination of a dipeptidyl...

  • Intensive blood glucose control for type 2 diabetes: meta-analysis.  // Africa Health;Mar2012, Vol. 34 Issue 3, p59 

    The article reports on a meta-analysis of intensive blood glucose control for type 2 diabetes, which found that intensive control could not minimize all-cause mortality, however, can increase the risk of severe hypoglycaemia by about 30%.

  • Exenatide more effective than insulinglargine in patients with type 2 diabetes.  // Australian Journal of Pharmacy;Feb2011, Vol. 92 Issue 1089, p71 

    The article presents a case study on the efficacy of exenatide on patients with type 2 diabetes. In the study, exenatide was compared with insulin gargine in adults with type 2 diabetes who had subtimum glycaemic control despite use of maximum tolerated doses of blood-glucose-lowering drugs for...

  • Antibacterials/insulin detemir/omeprazole interaction.  // Reactions Weekly;8/1/2013, Issue 1463, p9 

    The article presents a case study of an 82-year-old man with hypoglycaemia, which developed during treatment with amoxicillin, clarithromycin, omeprazole and insulin detemir for type 2 diabetes.

  • PEDIATRIC MANAGEMENT PROBLEMS. Belkengren, Richard; Sapala, Shirley // Pediatric Nursing;Mar/Apr2000, Vol. 26 Issue 2, p182 

    Presents the case of a 14-year-old female with Type I diabetes. Social and family history; Factors that contributed to the occurrence of hypoglycemia; Treatment for the disease.

  • Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes. Haak, Thomas // Clinical Medicine Insights: Endocrinology & Diabetes;2015, Issue 8, p1 

    Type 2 diabetes mellitus (T2DM) is a progressive condition requiring long-term treatment. Most patients with T2DM are unable to maintain normoglycemia using metformin alone; thus, combination therapy is a pivotal part of disease management. Addition of the dipeptidyl peptidase-4 inhibitor...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics